SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001437749-21-015171
Filing Date
2021-06-21
Accepted
2021-06-21 08:00:22
Documents
25
Period of Report
2021-06-21
Items
Item 7.01: Regulation FD Disclosure
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 FORM 8-K snbp20210620_8k.htm 8-K 24216
2 EXHIBIT 99.1 ex_258621.htm EX-99.1 29934
3 a01.jpg GRAPHIC 35781
4 a02.jpg GRAPHIC 175512
5 a03.jpg GRAPHIC 112829
6 a04.jpg GRAPHIC 66226
7 a05.jpg GRAPHIC 66480
8 a06.jpg GRAPHIC 88372
9 a07.jpg GRAPHIC 102330
10 a08.jpg GRAPHIC 94563
11 a09.jpg GRAPHIC 121309
12 a10.jpg GRAPHIC 74173
13 a11.jpg GRAPHIC 88394
14 a12.jpg GRAPHIC 64684
15 a13.jpg GRAPHIC 86432
16 a14.jpg GRAPHIC 74647
17 a15.jpg GRAPHIC 121407
18 a16.jpg GRAPHIC 59061
19 a17.jpg GRAPHIC 77523
20 a18.jpg GRAPHIC 66761
21 a19.jpg GRAPHIC 77618
22 a20.jpg GRAPHIC 72676
23 a21.jpg GRAPHIC 55823
24 a22.jpg GRAPHIC 38989
25 a23.jpg GRAPHIC 70764
  Complete submission text file 0001437749-21-015171.txt   2659922
Mailing Address 712 VISTA BLVD #305 WACONIA MN 55387
Business Address 712 VISTA BLVD #305 WACONIA MN 55387 9524791196
Panbela Therapeutics, Inc. (Filer) CIK: 0001029125 (see all company filings)

IRS No.: 870543922 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-39468 | Film No.: 211027462
SIC: 2834 Pharmaceutical Preparations